CHAIR |
Dr. Joseph M. Chalil is Senior Director, Clinical Development and Medical Affairs for DBV Technologies SA, a clinical-stage biopharmaceutical company involved in the field of immunotherapy. With more than 18 years of experience in medical affairs, clinical development in the pharmaceutical and biotech industry, he has additional experience in academic and consulting roles. He earned his M.D. at J.J.M. Medical College, an M.B.A. in Healthcare Management from Davenport University, and is a Fellow of the American College of Healthcare Executives. |
Ety Alcalay |
Ety Alcalay is the owner of VAS Aero Services. She sits on the board of The Hebrew University of Jerusalem, Israel, as well as the American Committee for the Weizmann Institute of Science. |
CHIE, Market Leader, Florida Blue |
Doug Bartel is a regional executive with Florida Blue (Blue Cross and Blue Shield of Florida), leading business strategy, planning, development, and execution in the largest MSA in Florida. He works to ensure the company responds nimbly to changing forces, technology as well as market and stakeholder needs, through strategic resource investment and utilization. Formerly, he was director of multimedia at the Dan Marino Foundation. He earned a bachelor’s degree in Communications from the University of Florida College of Journalism and Communications and an M.B.A. in Business/Health Sector Management from the University of Miami Herbert Business School. |
William C. Hawk, M.B.A. |
William C. Hawk is a retired Healthcare Senior Executive. Over 12 years with MEDNAX, he served in various leadership roles including President of the Ambulatory Services Division, Chief Operating Officer of the Clinical Services Division, and the American Anesthesiology Division, and Senior Vice President of Health Solutions Partner. Formerly, he was the President and Chief Executive Officer at Severn Healthcare, Inc. He is a member of the board of directors of Jack & Jill Children’s Center and a member of the executive committee of the Northeastern University Health Care Entrepreneur Forum. |
Marlow Hernandez, D.O., M.B.A., M.P.H. |
Dr. Marlow Hernandez is the co-founder and Chief Executive Officer of Cano Health. Cano Health's goals are to improve healthcare quality and reduce costs while delivering an unparalleled patient experience. He earned a bachelor’s degree in Neuroscience at the University of Miami, and his subsequent degrees - M.B.A., M.P.H., and D.O. - all from Nova Southeastern University. He is a Fellow of the American College of Physicians. |
Gary Mervak, J.D., M.B.A., Retired (former CFO) |
Gary Mervak is a retired executive with 40 years of experience in all aspects of healthcare, including strategic planning and budgeting. Prior to his retirement, he was Chief Financial Officer at HCA Mercy Hospital. He is a graduate of the University of Michigan, Concord Law School, and holds an M.B.A. from Eastern Michigan University. |
Matt Muhart |
Matt Muhart is the Executive Vice President and Chief Strategy Officer at Memorial Healthcare System. With 20+ years of healthcare industry experience, he has also worked as a Division Controller for HCA Healthcare - a for-profit hospital corporation, and as a Staff Accountant for Ernst & Young. He holds a bachelor’s degree in Accounting from Barry University and earned an M.B.A. at Florida International University. |
Haroula P. Norden, M.B.A., FACHE |
Haroula Protopapadakis Norden is Chief Operating Officer at Boca Raton Regional Hospital. Prior, she served as the Associate Administrator at Memorial Regional Hospital and Director of Business Development & Physician Relations at Memorial Healthcare System. She is a Fellow of the American College of Healthcare Executives, a past president of the American College of Healthcare Executives (ACHE), and a board member of Leadership Broward Foundation. Haroula earned her M.B.A. at Nova Southeastern University. |
Luis Salmun, M.D. |
Dr. Luis Salmun is the Owner and Chief Executive Officer of Interim HealthCare of Fort Lauderdale South. He is also the principal at LMS Consulting Firm, providing consulting services to the pharmaceutical and biotechnology industries. Previously, he was senior vice president of Global Medical Affairs at DBV Technologies, Chief Medical Officer at the Kwivik Medical Group, and an executive director at Boehringer-Ingelheim. |
Kenneth C. Wong, M.B.A., FACHE, Member, Board of Directors, Past President |
Kenneth C. Wong is a member of the Board of Directors for the American College of Healthcare Executives (ACHE) of South Florida. Over the past several years, he has served in various roles, including Chapter President in 2021. He is board-certified in healthcare management as a Fellow (FACHE) with the American College of Healthcare Executives. For nearly two decades, Kenneth has enjoyed working closely with all healthcare stakeholders, including patients, providers, administrators, health systems/hospitals, academia, and the community, to improve access and outcomes. Within healthcare management, Kenneth has held roles leading marketing, business development, strategic planning, physician and community relations. In the private sector, Kenneth has worked for several Fortune 100 companies within the pharmaceutical and medical device industry and received numerous awards for his efforts related to new product launches and market development initiatives. He earned an M.B.A. in international business from the H. Wayne Huizenga School of Business and Entrepreneurship at Nova Southeastern University. |
Célia V. Zinger, M.D., M.P.H., M.S. |
Dr. Célia V. Zinger is the Senior Medical Director of Medical Affairs at Ovid Therapeutics Inc., a New York-based biotech company working to develop medicines that transform the lives of people affected by rare neurological disorders. She is also a principal at CVZ Consulting LLC. An ophthalmology-trained physician with experience in the U.S. and international healthcare industry experience, she has also worked as the Director of Global Medical Affairs at Strategy at DBV Technologies, Director of Global Medical Affairs, Clinical Development at IMMUNE Pharmaceuticals Inc., Senior Analyst for LASER ANALYTICA, and as a Project Manager for MSD France (Merck & Co.). |